Related Experiment Video
Updated: Apr 17, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for
Rosemary Wyber1, Kathryn Taubert2, Stephen Marko3
1Telethon Institute for Child Health Research, Perth, Western Australia, Australia..
Abstract:
Benzathine penicillin G is an important antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and rheumatic heart disease. However, as rheumatic heart disease has receded as a public health priority in most high-income settings, attention to the supply, manufacture, and accessibility of benzathine penicillin G has declined. Concerns about the quality, efficacy, and innovation of the drug have emerged following plasma analysis and anecdotal reports from low-resource settings. This review collates core issues in supply and delivery of benzathine penicillin G as a foundation for concerted efforts to improve global quality and access. Opportunities for intervention and improvement are explored.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Endocarditis III: Medical Management
